GB202207557D0 - Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders - Google Patents
Flavonoid compound for use in the treatment of diseases and conditions associated with movement disordersInfo
- Publication number
- GB202207557D0 GB202207557D0 GBGB2207557.6A GB202207557A GB202207557D0 GB 202207557 D0 GB202207557 D0 GB 202207557D0 GB 202207557 A GB202207557 A GB 202207557A GB 202207557 D0 GB202207557 D0 GB 202207557D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diseases
- treatment
- conditions associated
- movement disorders
- flavonoid compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- -1 Flavonoid compound Chemical class 0.000 title 1
- 208000016285 Movement disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229930003935 flavonoid Natural products 0.000 title 1
- 235000017173 flavonoids Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2207557.6A GB202207557D0 (en) | 2022-05-24 | 2022-05-24 | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders |
GB2304262.5A GB2619147A (en) | 2022-05-24 | 2023-03-23 | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders |
PCT/GB2023/051356 WO2023227882A1 (en) | 2022-05-24 | 2023-05-24 | 4-(6-oxo-2-(trifluoromethyl)-3,6-dihydrochromeno[7,8-d]imidazol-8-yl)benzonitril e for the treatment of diseases and conditions associated with movement disorders |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2207557.6A GB202207557D0 (en) | 2022-05-24 | 2022-05-24 | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202207557D0 true GB202207557D0 (en) | 2022-07-06 |
Family
ID=82220585
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2207557.6A Ceased GB202207557D0 (en) | 2022-05-24 | 2022-05-24 | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders |
GB2304262.5A Pending GB2619147A (en) | 2022-05-24 | 2023-03-23 | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2304262.5A Pending GB2619147A (en) | 2022-05-24 | 2023-03-23 | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB202207557D0 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4344743A3 (en) * | 2018-08-07 | 2024-06-19 | Emory University | Heterocyclic flavone derivatives, compositions, and methods related thereto |
-
2022
- 2022-05-24 GB GBGB2207557.6A patent/GB202207557D0/en not_active Ceased
-
2023
- 2023-03-23 GB GB2304262.5A patent/GB2619147A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
GB2619147A (en) | 2023-11-29 |
GB202304262D0 (en) | 2023-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288214A (en) | Quinazolin-4-one derivatives useful for the treatment of braf-associated diseases and disorders | |
IL287032A (en) | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | |
EP3583113A4 (en) | Use of tgf alpha for the treatment of diseases and disorders | |
IL286636A (en) | Compositions and methods for the treatment of kras associated diseases or disorders | |
IL272253A (en) | Compositions and methods for treatment of inflammatory conditions and diseases of the skin | |
IL289167A (en) | 2h-indazole derivatives and their use in the treatment of disease | |
IL282562A (en) | Composition and use for the treatment of parkinson's disease and related disorders | |
EP3915985A4 (en) | Pyrrolopyridine derivative and use thereof in prevention and treatment of protein kinase-related disease | |
IL286268A (en) | Pridopidine for use in the treatment of mitochondrial associated diseases and disorders, including symptoms thereof | |
EP4010075A4 (en) | Methods for the treatment of apoc3-related diseases and disorders | |
PL3937948T3 (en) | Phytoecdysones and the derivatives thereof for use in the treatment of neuromuscular diseases | |
GB202304262D0 (en) | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders | |
GB202207559D0 (en) | Flavonoid compound for use in the treatment of diseases and conditions associated with movement disorders | |
EP3955914A4 (en) | Novel compounds and methods of use treating fructose-related disorders or diseases | |
IL309317A (en) | Treatment of mtres1 related diseases and disorders | |
TWI799923B (en) | Use of thioimidazolidinone drugs in the treatment of covid-19 disease | |
GB202211274D0 (en) | Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction | |
GB202207556D0 (en) | Flavonoid compound for use in the treatment of diseases and conditions associated with neurodegenerative dysfunction | |
GB202217454D0 (en) | Compounds for use in the treatment of diseases and conditions associated with anxiety and / or mood disorders | |
GB202217453D0 (en) | Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity | |
GB202208255D0 (en) | Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity | |
GB202208256D0 (en) | Compounds for use in the treatment of diseases and conditions associated with inflammation or autoimmunity | |
GB2603379B (en) | Avocatin B for the treatment of diseases and conditions | |
AU2022433340A1 (en) | COMPOUNDS AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IMPAIRED β-GALACTOSIDASE ACTIVITY | |
IL309576A (en) | Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |